Results 51 to 60 of about 1,274,904 (321)

The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses [PDF]

, 2020
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave
Feliciello, Isidoro, Procino, Alfredo
core   +1 more source

Aptamer‐based strategies against SARS‐CoV‐2 viruses

BMEMat, 2023
The COVID‐19 pandemic, caused by SARS‐CoV‐2, has seriously threatened human life and security in recent years and has had a serious impact on economic development. A range of strategies, including antibodies, small‐molecule agents and vaccines, have been
Yihao Huang, Ximing Chen, Jialu Zhang, Wenhai Tian, Siwen Liu, Rachel Chun‐Yee Tam, Chaoyong Yang, Yanling Song   +7 more
doaj   +1 more source

Survival and disinfection of SARS-Cov-2 in environment and contaminated surface [PDF]

, 2020
The detection of SARS-Cov-2 in the sewage and water resources has increased the awareness among the people about the possibility survival of SARS-Cov-2 in the environment and the potential to transmit into the human through food chain or water resources.
Al-Gheethi, Adel, Al-Maqtari, Qais, Almoheer, Reyad, Hamdan, Rafidah, Noman, Efaq, Radin Mohamed, Radin Maya Saphira   +5 more
core  

Evolutionary Multi-Objective Design of SARS-CoV-2 Protease Inhibitor Candidates

, 2020
Computational drug design based on artificial intelligence is an emerging research area. At the time of writing this paper, the world suffers from an outbreak of the coronavirus SARS-CoV-2.
A Alhossary, CA Lipinski, CA Nicolaou, D Douguet, D Weininger, E van der Horst, E Zitzler, GR Bickerton, H Nguyen, HG Beyer, K Deb, L Zhang, N Brown, N Brown, O Trott, P Ertl, P Ertl, RF de Freitas, RV Devi, SCH Pegg, SS Kaplan, T Gaillard, T Krause, TT Wager, W Dai   +24 more
core   +1 more source

Investigating the Dark Figure of COVID-19 Cases in Austria: Borrowing From the Decode Genetics Study in Iceland [PDF]

, 2020
The number of undetected cases of SARS-CoV-2 infections is expected to be a multiple of the reported figures mainly due to the assumed high proportion of asymptomatic infections and to limited availability of trustworthy testing resources. Relying on the
Hirk, Rainer, Kastner, Gregor, Vana, Laura   +2 more
core   +1 more source

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Nature Microbiology, 2020
The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences.
A. Rambaut, E. Holmes, Á. O'toole, V. Hill, J. McCrone, C. Ruis, L. du Plessis, O. Pybus   +7 more
semanticscholar   +1 more source

Molecular Crowding Modulates SARS‐CoV‐2 Aptamer Affinity

Small Structures, 2023
SARS‐CoV‐2 aptamer is a favorable candidate for the recognition and detection of SARS‐CoV‐2, owing to its small size and easy synthesis. However, the issue of compromised binding affinities in real samples and targeting mutant SARS‐CoV‐2 hinder wide ...
Ting Song, Miao Sun, Jialu Zhang, Yinzhu Lu, Shuang Wan, Chaoyong Yang, Yanling Song   +6 more
doaj   +1 more source

COVID-19 publications: Database coverage, citations, readers, tweets, news, Facebook walls, Reddit posts [PDF]

, 2020
© 2020 The Authors. Published by MIT Press. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1162/qss_a_00066The COVID ...
Adie E., Chen Q., Clark F., Colavizza G., Costas R., de Solla Price D., Delwiche F. A., Fairclough R., Gunn W., Harzing A. W., Haustein S., Haustein S., Haustein S., Holmberg K., Ioannidis J. P., Kostoff R. N., Kousha K., Kousha K., Lewison G., Merchant R. M., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Orduña-Malea E., Ortega J. L., Ortega J. L., Ovadia S., Pouris A., Pouris A., Rethlefsen M. L., Robinson-García N., Robinson-García N., Song P., Stegehuis C., Stoddard G., Sud P., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Tian D., Torres-Salinas D., Van Noorden R., Wallace M. L., WHO, Yu H., Zahedi Z., Zahedi Z., Zahedi Z.   +54 more
core   +2 more sources

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Nature Communications, 2020
Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002–2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019. However, little is currently known about the biology of SARS-CoV-2.
Xiuyuan Ou, Yan Liu, X. Lei, Pei Li, Dan Mi, L. Ren, Li Guo, Ruixuan Guo, Ting Chen, Jiaxin Hu, Zichun Xiang, Z. Mu, Xing Chen, Jieyong Chen, Keping Hu, Q. Jin, Jianwei Wang, Zhaohui Qian   +17 more
semanticscholar   +1 more source

Monitoring of SARS‐CoV‐2 infection in mustelids

EFSA Journal, 2021
American mink and ferret are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but no information is available for other mustelid species.
European Food Safety Authority and European Centre for Disease Prevention and Control, Anette Boklund, Christian Gortázar, Paolo Pasquali, Helen Roberts, Søren Saxmose Nielsen, Karl Stahl, Arjan Stegeman, Francesca Baldinelli, Alessandro Broglia, Yves Van Der Stede, Cornelia Adlhoch, Erik Alm, Angeliki Melidou, Grazina Mirinaviciute   +14 more
doaj   +1 more source